Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Vanda Pharmaceuticals	Urogen Pharma	Provention Bio	MacroGenics	BioXcel Therapeutics
Symbol	NASDAQ:VNDA	NASDAQ:URGN	NASDAQ:PRVB	NASDAQ:MGNX	NASDAQ:BTAI
Price Information
Current Price	$10.61	$19.88	$8.39	$5.29	$19.67
52 Week Range	Hold	Buy	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Hold	Buy	Buy	Buy	Buy
Consensus Price Target	$16.00	$47.67	$27.50	$18.91	$51.00
% Upside from Price Target	50.80% upside	139.77% upside	227.77% upside	257.45% upside	159.28% upside
Trade Information
Market Cap	$550.97 million	$418.84 million	$372.61 million	$276.11 million	$406.02 million
Beta	0.43	1.69	4.86	2.19	1.53
Average Volume	747,126	192,060	616,365	531,830	658,231
Sales & Book Value
Annual Revenue	$227.19 million	$20,000.00	N/A	$64.19 million	N/A
Price / Sales	2.51	20,771.62	N/A	4.05	N/A
Cashflow	$2.23 per share	N/A	N/A	N/A	N/A
Price / Cash	4.75	N/A	N/A	N/A	N/A
Book Value	$7.70 per share	$8.63 per share	$1.72 per share	$4.71 per share	$1.49 per share
Price / Book	1.38	2.30	N/A	1.12	N/A
Profitability
Net Income	$115.55 million	$-105,150,000.00	$-43,280,000.00	$-151,810,000.00	$-32,970,000.00
EPS	$2.11	($5.12)	($1.06)	($3.16)	($2.02)
Trailing P/E Ratio	5.00	N/A	N/A	N/A	N/A
Forward P/E Ratio	20.80	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	50.86%	N/A	N/A	-236.51%	N/A
Return on Equity (ROE)	33.33%	-49.16%	-66.62%	-55.16%	-110.97%
Return on Assets (ROA)	27.48%	-45.73%	-62.57%	-41.53%	-85.25%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	0.12%	0.04%
Current Ratio	5.95%	7.63%	22.40%	5.31%	4.03%
Quick Ratio	5.93%	7.63%	22.39%	5.31%	4.03%
Ownership Information
Institutional Ownership Percentage	98.54%	67.29%	18.45%	92.87%	21.53%
Insider Ownership Percentage	8.20%	10.50%	19.60%	7.88%	64.80%
Miscellaneous
Employees	270	70	13	364	18
Shares Outstanding	53.65 million	20.90 million	47.71 million	49.13 million	20.18 million
Next Earnings Date	5/6/2020 (Estimated)	5/14/2020 (Estimated)	5/13/2020 (Estimated)	5/6/2020 (Estimated)	5/5/2020 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Optionable	Not Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources